CHICAGO , Aug. 21, 2024 /PRNewswire/ -- The global Microsampling Devices Market is valued at an estimated USD 93 million in 2024 and is projected to reach USD 135 million by 2029 at a CAGR of 7.6% during the forecast period.
The microsampling devices market is driven by advancements in technology making devices less invasive and user-friendly, such as bladeless or needle-free sampling, coupled with growing consumer awareness and demand for proactive health management. Regulatory approvals enhance device safety and efficiency, boosting consumer confidence. Efforts to reduce prices are making devices more affordable, especially in emerging economies like India , Brazil , and Mexico , where the large patient population, rising disposable income, and improved healthcare infrastructure create opportunities for growth.
The rising burden of chronic disorders, such as diabetes and cardiovascular conditions, also fuels demand for microsampling devices, which offer a convenient way to monitor health metrics from home. However, challenges such as the uncontrolled use of unapproved blood collection products at home, low access in resource-limited settings, and gaps in supply chains hinder widespread adoption in developing regions. Fingerstick devices and self-collection methods held the largest market shares in 2023 due to their simplicity and ease of use for frequent home health monitoring.
The health screening & preventive health segment dominated the market, driven by the increasing f.